Covalent binding of non-proteolysed C3 to jurkat T cellsBARRO, C. D; VILLIERS, C. L; COLOMB, M. G et al.Molecular immunology. 1991, Vol 28, Num 7, pp 711-717, issn 0161-5890Article

Decrease of Fcy and C3b receptor-vearing granulocytes and of T lymphocytes in myelomatosisNAESS, A; HOPEN, G; SOLBERG, C. O et al.Scandinavian journal of haematology. 1984, Vol 33, Num 1, pp 83-90, issn 0036-553XArticle

Impaired intestinal tolerance in the absence of a functional complement systemPEKKARINEN, Pirkka T; VAALI, Kirsi; JARVA, Hanna et al.Journal of allergy and clinical immunology. 2013, Vol 131, Num 4, pp 1167-1175, issn 0091-6749, 9 p.Article

RECEPTORS FOR ACTIVATED C3 ON THYMUS-DEPENDENT (T) LYMPHOCYTES OF NORMAL GUINEA-PIGWILSON AB; PRICHARD THOMAS S; COOMBS RRA et al.1979; IMMUNOLOGY; GBR; DA. 1979; VOL. 37; NO 2; PP. 377-384; BIBL. 23 REF.Article

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMAILLET, F; KAZATCHKINE, M. D; GLOTZ, D et al.Molecular immunology. 1983, Vol 20, Num 12, pp 1401-1404, issn 0161-5890Article

EXPRESSION AND MODULATION OF C3 RECEPTORS DURING EARLY T-CELL ONTOGENYSHORE A; DOSCH HM; GELFAND EW et al.1979; CELL. IMMUNOL.; USA; DA. 1979; VOL. 45; NO 1; PP. 157-166; BIBL. 34 REF.Article

EPSTEIN-BARR VIRUS (EBV) RECEPTORS, COMPLEMENT RECEPTORS, AND EBV INFECTIBILITY OF DIFFERENT LYMPHOCYTE FRACTIONS OF HUMAN PERIPHERAL BLOOD. I. COMPLEMENT RECEPTOR DISTRIBUTION AND COMPLEMENT BINDING BY SEPARATED LYMPHOCYTE SUBPOPULATIONS.YEFENOF E; BAKACS T; EINHORN L et al.1978; CELL. IMMUNOL.; U.S.A.; DA. 1978; VOL. 35; NO 1; PP. 34-42; BIBL. 20 REF.Article

Modelling C₃ photosynthesis from the chloroplast to the ecosystemBERNACCHI, Carl J; BAGLEY, Justin E; SERBIN, Shawn P et al.Plant, cell and environment (Print). 2013, Vol 36, Num 9, pp 1641-1657, issn 0140-7791, 17 p.Article

Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokinesPASCH, M. C; VAN DEN BOSCH, N. H. A; DAHA, M. R et al.Journal of investigative dermatology. 2000, Vol 114, Num 1, pp 78-82, issn 0022-202XConference Paper

Effects of UVB on the synthesis of complement proteins by keratinocytesPASCH, M. C; OKADA, N; BOS, J. D et al.Journal of investigative dermatology. 1998, Vol 111, Num 4, pp 683-688, issn 0022-202XArticle

Primed CD8⁺ T Cell Responses to Allogeneic Endothelial Cells Are Controlled by Local Complement ActivationRAEDLER, H; YANG, M; LALLI, P. N et al.American journal of transplantation (Print). 2009, Vol 9, Num 8, pp 1784-1795, issn 1600-6135, 12 p.Article

C3-REACTED SEPHAROSE: A PREPARATIVE METHOD FOR SEPARATING T AND B LYMPHOCYTES.CASALI P; PERUSSIA BM.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 1; PP. 38-42; BIBL. 17 REF.Article

Steady-state models of photosynthesisVON CAEMMERER, Susanne.Plant, cell and environment (Print). 2013, Vol 36, Num 9, pp 1617-1630, issn 0140-7791, 14 p.Article

La protéine C3 du complément humain: étude de sa fixation sur les lymphocytes T Jurkat et de son rôle fonctionnel dans l'activation T = Analysis of human complement C3 protein binding to Jurkat T lymphocytes: role in cell activationBarro, Claire; Colomb, Maurice.1992, 141 p.Thesis

Enhancing C₃ PhotosynthesisVON CAEMMERER, Susanne; EVANS, John R.Plant physiology (Bethesda). 2010, Vol 154, Num 2, pp 589-592, issn 0032-0889, 4 p.Article

Reduction of the β-Cys-γ-Glu thiol ester bond of human C3 with sodium borohydrideTHOMAS, M. L; DAVIDSON, F. F; TACK, B. F et al.The Journal of biological chemistry (Print). 1983, Vol 258, Num 22, pp 13580-13586, issn 0021-9258Article

Response of perennial cool-season grasses to clipping in the Southern PlainsGILLEN, Robert L; BERG, William A.Agronomy journal (Print). 2005, Vol 97, Num 1, pp 125-130, issn 0002-1962, 6 p.Article

The effects of scale: variation in the APOA1/C3/A4/A5 gene clusterFULLERTON, Stephanie M; BUCHANAN, Anne V; NICKERSON, Deborah A et al.Human genetics. 2004, Vol 115, Num 1, pp 36-56, issn 0340-6717, 21 p.Article

Nomenclature for human complement factor B : WHO-IUIS nomenclature sub-committeeJournal of immunological methods. 1993, Vol 163, Num 1, pp 9-11, issn 0022-1759Article

Clinicopathological study of patients with mesangial isolated C3d deposition in various glomerular diseasesDOI, T; KANATSU, K; SUEHIRO, F et al.Nephron. 1987, Vol 46, Num 2, pp 188-193, issn 0028-2766Article

Isolation of the C3 complement component and its C3d subunit from IY-1 fraction of Cohn's fractionation of human plasmaMATVEEVSKAYA, N. S; ALYOSHKIN, V. A; ROZINA, M. N et al.Journal of chromatography. B, Biomedical applications. 1995, Vol 664, Num 1, pp 261-266Conference Paper

ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN THE NEWBORN INFANTADAMKIN D; STITZEL A; URMSON J et al.1978; J. PEDIATR.; USA; DA. 1978; VOL. 93; NO 4; PP. 604-608; BIBL. 24 REF.Article

Cutaneous IgA-associated vasculitis induced by alcoholCHUA, I. C; ALDRIDGE, C. R; FINLAY, A. Y et al.British journal of dermatology (1951). 2005, Vol 153, Num 5, pp 1037-1040, issn 0007-0963, 4 p.Article

Two BF F subtypes no BF S, BF Fl or BF SO7 subdivision, are found by isoelectric focusingSEGURADO, O. G; ARNAIZ-VILLENA, A.Vox sanguinis (Basel. 1956). 1989, Vol 56, Num 2, pp 117-121, issn 0042-9007Article

Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement sourcePLOUG, M; JESSEN, T. E; WELINDER, K. G et al.Analytical biochemistry. 1985, Vol 146, Num 2, pp 411-417, issn 0003-2697Article